Novel Size-Variable Dedicated Rodent Oxygenator for ECLS Animal Models-Introduction of the "RatOx" Oxygenator and Preliminary In Vitro Results

The overall survival rate of extracorporeal life support (ECLS) remains at 60%. Research and development has been slow, in part due to the lack of sophisticated experimental models. This publication introduces a dedicated rodent oxygenator ("RatOx") and presents preliminary in vitro classi...

Full description

Saved in:
Bibliographic Details
Published inMicromachines (Basel) Vol. 14; no. 4; p. 800
Main Authors Strudthoff, Lasse J, Focke, Jannis, Hesselmann, Felix, Kaesler, Andreas, Martins Costa, Ana, Schlanstein, Peter C, Schmitz-Rode, Thomas, Steinseifer, Ulrich, Steuer, Niklas B, Wiegmann, Bettina, Arens, Jutta, Jansen, Sebastian V
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 31.03.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The overall survival rate of extracorporeal life support (ECLS) remains at 60%. Research and development has been slow, in part due to the lack of sophisticated experimental models. This publication introduces a dedicated rodent oxygenator ("RatOx") and presents preliminary in vitro classification tests. The RatOx has an adaptable fiber module size for various rodent models. Gas transfer performances over the fiber module for different blood flows and fiber module sizes were tested according to DIN EN ISO 7199. At the maximum possible amount of effective fiber surface area and a blood flow of 100 mL/min, the oxygenator performance was tested to a maximum of 6.27 mL O /min and 8.2 mL CO /min, respectively. The priming volume for the largest fiber module is 5.4 mL, while the smallest possible configuration with a single fiber mat layer has a priming volume of 1.1 mL. The novel RatOx ECLS system has been evaluated in vitro and has demonstrated a high degree of compliance with all pre-defined functional criteria for rodent-sized animal models. We intend for the RatOx to become a standard testing platform for scientific studies on ECLS therapy and technology.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
All authors are affiliated with the DFG priority program “SPP2014—Towards an Implantable Lung”.
These authors contributed equally to this work.
ISSN:2072-666X
2072-666X
DOI:10.3390/mi14040800